Filing Details

Accession Number:
0001127602-18-023565
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-19 08:37:27
Reporting Period:
2018-07-17
Accepted Time:
2018-07-19 08:37:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100682 Charles River Laboratories International Inc CRL Services-Commercial Physical & Biological Research (8731) 061397316
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1507332 Davide Molho 251 Ballardvale Street
Wilmington MA 01887
President & Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-17 6,165 $76.67 44,805 No 4 M Direct
Common Stock Disposition 2018-07-17 11,126 $120.00 33,679 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2018-07-17 6,165 $0.00 6,165 $76.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,165 2016-02-27 2020-02-27 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 40,748 Indirect By Revocable Trust
Footnotes
  1. This sale occurred pursuant to a 10b5-1 Trading Plan.
  2. On 3/08/2018: 3,514 shares were transferred from Direct Holdings to the Revocable Trust. On 6/05/2018: 21,485 shares were transferred from the Revocable Trust to Direct Holdings.
  3. On 3/08/2018: 3,514 shares were transferred from Direct Holdings to the Revocable Trust. On 6/05/2018: 21,485 shares were transferred from the Revocable Trust to Direct Holdings.